HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Khalid A Mohamedali Selected Research

Gelonium multiflorum GEL protein

1/2012Cell-targeting fusion constructs containing recombinant gelonin.
8/2011Cytotoxicity of VEGF(121)/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2.
3/2007Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.
11/2006Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel.
12/2005Vascular targeting of ocular neovascularization with a vascular endothelial growth factor121/gelonin chimeric protein.
5/2005The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Khalid A Mohamedali Research Topics

Disease

25Neoplasms (Cancer)
01/2020 - 05/2005
5Breast Neoplasms (Breast Cancer)
11/2014 - 05/2005
3Glioblastoma (Glioblastoma Multiforme)
07/2012 - 12/2006
3Neoplasm Metastasis (Metastasis)
04/2011 - 05/2005
2Melanoma (Melanoma, Malignant)
04/2013 - 10/2010
2Urinary Bladder Neoplasms (Bladder Cancer)
07/2011 - 10/2005
1Necrosis
04/2013
1Hematologic Neoplasms (Hematological Malignancy)
01/2012
1Prostatic Neoplasms (Prostate Cancer)
04/2011
1Myocardial Infarction
04/2008
1Choroidal Neovascularization
12/2005
1Retinal Neovascularization
12/2005

Drug/Important Bio-Agent (IBA)

14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 05/2005
8Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2005
6Gelonium multiflorum GEL proteinIBA
01/2012 - 05/2005
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2012 - 05/2005
3Granzymes (Granzyme)IBA
07/2019 - 10/2013
3Pharmaceutical PreparationsIBA
10/2018 - 08/2011
3Immunotoxins (Immunotoxin)IBA
06/2013 - 01/2012
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2008 - 10/2005
2Serine Proteases (Serine Protease)IBA
07/2019 - 10/2013
2TWEAK ReceptorIBA
11/2014 - 04/2013
2Peptides (Polypeptides)IBA
06/2013 - 07/2012
2Contrast MediaIBA
07/2012 - 07/2011
2Protein Isoforms (Isoforms)IBA
03/2007 - 02/2007
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
03/2007 - 12/2006
1Immunoconjugates (Immunoconjugate)IBA
01/2020
1Cytokine TWEAKIBA
11/2014
1N- phenylacetoaminomethylene- DL- p- nitrophenylalanine (A 101)IBA
11/2014
1Hormones (Hormone)IBA
11/2014
1Messenger RNA (mRNA)IBA
11/2014
1Bleomycin (Blenoxane)FDA LinkGeneric
04/2014
1Trastuzumab (Herceptin)FDA Link
06/2013
1Lapatinib (GW572016)FDA Link
06/2013
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
04/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2013
1Indicators and Reagents (Reagents)IBA
04/2013
1Cell Surface ReceptorsIBA
04/2013
1Single-Chain AntibodiesIBA
01/2012
1Ethylene Glycol (Monoethylene Glycol)IBA
08/2011
1CarbonIBA
08/2011
1Cetuximab (Erbitux)FDA Link
08/2011
1ErbB Receptors (EGF Receptor)IBA
08/2011
1Monoclonal AntibodiesIBA
08/2011
1Paclitaxel (Taxol)FDA LinkGeneric
08/2011
1manganese ferriteIBA
07/2011
1Glucose (Dextrose)FDA LinkGeneric
04/2011
1fluoromisonidazoleIBA
04/2011
1AntigensIBA
10/2010
1RadiopharmaceuticalsIBA
12/2006
1AcidsIBA
12/2006
1AntibodiesIBA
10/2005
1Biotin (Vitamin H)FDA Link
10/2005
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
10/2005

Therapy/Procedure

8Therapeutics
10/2018 - 12/2006
1Cell- and Tissue-Based Therapy (Cell Therapy)
07/2019
1Intravenous Administration
06/2013
1Aftercare (After-Treatment)
03/2007
1Intraocular Injections
12/2005
1Intravenous Injections
12/2005